Clinical Outcomes, Predictors, and Surgical Management of Primary Pulmonary Vein Stenosis
- PMID: 33745903
- DOI: 10.1016/j.athoracsur.2021.03.015
Clinical Outcomes, Predictors, and Surgical Management of Primary Pulmonary Vein Stenosis
Abstract
Background: Surgical outcomes for primary pulmonary vein stenosis (PPVS) remain unfavorable, and risk factors are still poorly understood. This study evaluated outcomes and risk factors after PPVS repair.
Methods: This retrospective study included 40 patients with PPVS who underwent surgical repair in Fuwai Hospital from 2010 to 2020. Adverse outcomes included overall death, pulmonary vein (PV) restenosis, and reintervention. A univariate and multivariate risk analysis was performed to determine risk factors.
Results: The mean follow-up duration was 37.5 ± 31.5 months. Sutureless technique was performed in 7 patients (17.5%), endovenectomy in 9 (22.5%), and patch venoplasty in 24 (60%). Bilateral PV involvement was documented in 12 patients (30%). Overall death, PV reintervention, and restenosis occurred in 15%, 12.5%, and 25% of patients, respectively. Freedom from overall death, PV reintervention, and restenosis at 5 years was 85% ± 6.3%, 88.9% ± 5.2%, and 65.1% ± 13.2%, respectively. Multivariate analysis revealed that bilateral PV involvement was an independent risk factor for death or PV reintervention (hazard ratio, 10.4; 95% confidence interval, 1.9-56; P = .006) and that involvement of the left inferior PV was an independent risk factor for postoperative restenosis of the left inferior PV (hazard ratio, 13.1; 95% confidence interval, 2.2-76.8; P = .004).
Conclusions: Surgical treatment for PPVS remains a challenging issue with imperfect prognosis. Therefore, it is right and appropriate to take close surveillance on mild or moderate stenosis on a single PV. Bilateral and left inferior PV involvement are independent risk factors for adverse outcomes.
Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Outcomes and prognostic factors for postsurgical pulmonary vein stenosis in the current era.J Thorac Cardiovasc Surg. 2018 Jul;156(1):278-286. doi: 10.1016/j.jtcvs.2018.02.038. Epub 2018 Feb 23. J Thorac Cardiovasc Surg. 2018. PMID: 29576261
-
Primary Pulmonary Vein Stenosis: Outcomes, Risk Factors, and Severity Score in a Multicentric Study.Ann Thorac Surg. 2017 Jul;104(1):182-189. doi: 10.1016/j.athoracsur.2017.03.022. Ann Thorac Surg. 2017. PMID: 28633223
-
Long-term outcomes of individualised repair in patients with primary pulmonary vein stenosis.Cardiol Young. 2025 Feb 18:1-10. doi: 10.1017/S1047951124026180. Online ahead of print. Cardiol Young. 2025. PMID: 39961772
-
Intraluminal Pulmonary Vein Stenosis in Children: A "New" Lesion.Anesth Analg. 2019 Jul;129(1):27-40. doi: 10.1213/ANE.0000000000003924. Anesth Analg. 2019. PMID: 30451723 Review.
-
Primary pulmonary vein stenosis during infancy: state of the art review.J Perinatol. 2021 Jul;41(7):1528-1539. doi: 10.1038/s41372-021-01008-7. Epub 2021 Mar 5. J Perinatol. 2021. PMID: 33674714 Review.
Cited by
-
Losartan attenuates upstream vasculopathy in a modified piglet model of pulmonary vein stenosis: contribution of the Hippo pathway.Ann Transl Med. 2022 Nov;10(21):1153. doi: 10.21037/atm-22-2621. Ann Transl Med. 2022. PMID: 36467357 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources